Phase III Trial Costs Estimated at $19 Million
It cost an average of $19 million to get new drugs through their pivotal clinical trials and onto the market, a new analysis has found.
Source: Drug Industry Daily
It cost an average of $19 million to get new drugs through their pivotal clinical trials and onto the market, a new analysis has found.
Source: Drug Industry Daily